Post advising GP practices to exercise both caution and monitoring when prescribing Carbamazepine and Diltiazem simultaneously to prevent patient harm.
Latest News
Advisory information in relation to prescribing of TrueYou test strips
Clinical Safety advisory communication regarding issue in relation to the way that eGFR result data extracted from Vision is being displayed on SCI-DC.
Issue with recently updated eGFR calculator in Vision+ available from December 2019. The calculator may be used to estimate renal function in patients.
Please be advised of the need to be vigilant when co-prescribing opiates and tricyclic anti-depressants, especially Oxycodone and Amitriptyline, in view of the risk of over-sedation. Extra caution is advised in patients who have underlying respiratory conditions.
Vision has implemented "High Risk" similar drug name warnings to meet requirements and in response to a MHRA drug safety update and ISMP safety alert.
We have been made aware of a potential issue in relation to the use of the Last Run reporting feature available within the Vision+ application. It is possible to add an entry to the record of a patient included within a Last Run report.